Sernova Biotherapeutics (OTCMKTS:SEOVF) Issues Earnings Results

Sernova Biotherapeutics (OTCMKTS:SEOVF) released its quarterly earnings results on Thursday. The company reported ($0.01) EPS for the quarter, hitting analysts’ consensus estimates of ($0.01), Zacks reports.

Sernova Biotherapeutics Stock Performance

Shares of Sernova Biotherapeutics stock remained flat at $0.11 during trading hours on Thursday. The stock had a trading volume of 620 shares, compared to its average volume of 25,062. Sernova Biotherapeutics has a 1-year low of $0.09 and a 1-year high of $0.16. The firm has a 50-day moving average of $0.12 and a two-hundred day moving average of $0.11. The company has a market capitalization of $41.54 million, a price-to-earnings ratio of -2.75 and a beta of 0.82.

Sernova Biotherapeutics Company Profile

Sernova Biotherapeutics is a clinical?stage biotechnology company focused on developing and commercializing cell?based therapeutic technologies for patients with chronic and life?threatening diseases. Headquartered in London, Ontario, Canada, the firm is advancing an implantable device platform designed to support the long-term survival and function of therapeutic cells. The company’s lead product candidate, known as the Cell Pouch System, is engineered to create a vascularized environment in which transplanted cells can thrive, with an initial emphasis on treating patients with type 1 diabetes.

In its core program, Sernova has initiated a Phase I/II clinical trial evaluating the safety and efficacy of the Cell Pouch System in individuals with type 1 diabetes who require islet cell transplantation.